Table 2.
Effects of melatonin on the cardiological and nephrological function parameters among all groups (mean ± SEM).
| Item | Urea (mg/dl) | Creatinine (mg/dl) | CK-MB (U/L) | TNO (μM/ml) | Endothelin-1 (pg/ml) | Myogb (ng/ml) | H-FABP (ng/ml) | TAC (mmol/L) | TOC (mmol/L) |
|---|---|---|---|---|---|---|---|---|---|
| Control | 47.56 ± 3.82a | 0.6 ± 0.04a | 14.39 ± 0.13a | 54.73 ± 0.22a | 0.38 ± 0.003a | 32.51 ± 0.34a | 15.18 ± 0.06a | 1.44 ± 0.01a | 0.38 ± 0.00a |
| DM | 105.72 ± 6.34b | 0.71 ± 0.02b | 27.09 ± 0.22b | 37.09 ± 0.48b | 0.74 ± 0.011b | 70.41 ± 0.46b | 32.26 ± 0.25b | 0.78 ± 0.01b | 0.82 ± 0.00b |
| MLT | 50.09 ± 2.01a | 0.69 ± 0.03bc | 14.16 ± 0.07a | 54.48 ± 0.25a | 0.38 ± 0.003a | 32.36 ± 0.35a | 15.11 ± 0.08a | 1.44 ± 0.00a | 0.38 ± 0.00a |
| DM + MLT | 112.76 ± 7.38b | 0.73 ± 0.01b | 22.39 ± 0.30c | 42.81 ± 0.57c | 0.54 ± 0.015c | 51.95 ± 0.32c | 24.09 ± 0.18c | 0.94 ± 0.00c | 0.60 ± 0.01c |
| DM + INS | 89.18 ± 7.38c | 0.64 ± 0.03ac | 19.54 ± 0.18d | 48.89 ± 0.22d | 0.43 ± 0.013d | 44.80 ± 0.34d | 20.13 ± 0.33d | 1.15 ± 0.03d | 0.52 ± 0.00d |
Means in the same column with different superscripts are significant at a P-value of < 0.05.
CK-MB, creatine kinase-MB; TNO, total nitric oxide; Myogb, myoglobin; H-FABP, cardiac fatty acid-binding protein; TAC, total antioxidative capacity; TOC, total oxidative capacity.